906.3500 -4.05 (-0.44%)
NSE Oct 06, 2025 15:31 PM
Volume: 67,670
 

906.35
-0.44%
ICICI Securities Limited
Specialty contribution in the domestic branded space increased to 63% in FY19 from 54% in FY14. With ~3900 MRs at its disposal, the company enjoys a wide reach among doctors. We expect the specialty segment to remain a key driver for domestic market on the back of aggressive product launches and constant addition of new speciality segments & sub-segments....
Alembic Pharmaceuticals Ltd. is trading below all available SMAs
More from Alembic Pharmaceuticals Ltd.
Recommended